Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Janus kinase inhibitors show promise for treating alopecia areata in children.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

The nanofiber membranes effectively promote wound healing and have strong antibacterial properties.

Vitiligo and alopecia areata may have similar causes despite their differences.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Ulcerative colitis can cause skin issues due to immune system problems.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Dupilumab helps children with alopecia areata regrow hair safely.

Hair gels may cause split ends in children.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.